Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,103 | 171 | 99.8% |
| Education | $4.90 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $645.32 | 39 | $0 (2021) |
| CSL Behring | $529.76 | 34 | $0 (2021) |
| Mylan Specialty L.P. | $411.25 | 39 | $0 (2018) |
| Genentech USA, Inc. | $312.92 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $300.04 | 12 | $0 (2021) |
| GENZYME CORPORATION | $154.83 | 5 | $0 (2020) |
| Pharming Healthcare, Inc. | $113.35 | 4 | $0 (2019) |
| Zimmer Biomet Holdings, Inc. | $96.75 | 1 | $0 (2018) |
| BioCryst US Sales Co., LLC | $90.81 | 5 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $82.42 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.22 | 5 | Genentech USA, Inc. ($219.19) |
| 2021 | $442.96 | 25 | CSL Behring ($107.89) |
| 2020 | $295.44 | 18 | CSL Behring ($120.38) |
| 2019 | $525.49 | 24 | AstraZeneca Pharmaceuticals LP ($151.32) |
| 2018 | $904.74 | 51 | GlaxoSmithKline, LLC. ($296.83) |
| 2017 | $702.27 | 49 | Mylan Specialty L.P. ($248.73) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $130.48 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/02/2024 | Genentech USA, Inc. | Perjeta (Biological), Phesgo, Polivy | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: BioOncology | ||||||
| 07/02/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 11/18/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.31 | General |
| 11/11/2021 | USWM, LLC | SYMJEPI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Immunology | ||||||
| 11/01/2021 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
| 10/25/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Respiratory | ||||||
| 10/18/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.16 | General |
| 10/04/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Immunology | ||||||
| 09/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 08/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: GENETIC DISEASE | ||||||
| 08/12/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2021 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Immunology | ||||||
| 06/14/2021 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Immunology | ||||||
| 05/24/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology | ||||||
| 05/20/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Respiratory | ||||||
| 05/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: RESPIRATORY | ||||||
| 04/22/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Immunology | ||||||
| 04/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: GENETIC DISEASE | ||||||
| 03/29/2021 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Immunology | ||||||
| 03/01/2021 | CSL Behring | Haegarda (Biological), Kcentra | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 108 | 380 | $11,773 | $6,552 |
| 2022 | 4 | 104 | 732 | $16,436 | $8,515 |
| 2021 | 7 | 272 | 2,905 | $101,365 | $37,026 |
| 2020 | 7 | 259 | 2,671 | $91,164 | $33,417 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 57 | 64 | $5,248 | $2,896 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $2,640 | $1,580 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $1,573 | $760.87 | 48.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $1,212 | $684.42 | 56.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Facility | 2023 | 11 | 275 | $1,100 | $630.03 | 57.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 48 | $5,808 | $3,198 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $3,630 | $2,250 | 62.0% |
| 95004 | Test for allergy using allergenic extract | Facility | 2022 | 13 | 639 | $5,112 | $1,981 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 23 | 23 | $1,886 | $1,086 | 57.6% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 37 | 1,388 | $36,088 | $16,175 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 106 | $22,510 | $9,118 | 40.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $15,000 | $5,797 | 38.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 33 | 1,112 | $20,016 | $3,452 | 17.2% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 19 | 214 | $4,280 | $1,447 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,865 | $610.27 | 32.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 20 | 22 | $1,606 | $425.64 | 26.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 45 | 1,651 | $42,926 | $17,644 | 41.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 93 | $16,740 | $7,450 | 44.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $9,300 | $3,440 | 37.0% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 24 | 728 | $13,104 | $2,276 | 17.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 41 | $5,494 | $1,540 | 28.0% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2020 | 11 | 107 | $2,140 | $657.65 | 30.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 19 | 20 | $1,460 | $409.23 | 28.0% |
About Dr. Robert Smith, MD
Dr. Robert Smith, MD is a Allergy & Immunology healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538113337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Smith, MD has received a total of $3,108 in payments from pharmaceutical and medical device companies, with $237.22 received in 2024. These payments were reported across 172 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,103).
As a Medicare-enrolled provider, Smith has provided services to 743 Medicare beneficiaries, totaling 6,688 services with total Medicare billing of $85,509. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Sioux Falls, SD
- Active Since 05/19/2006
- Last Updated 06/15/2016
- Taxonomy Code 207RA0201X
- Entity Type Individual
- NPI Number 1538113337
Products in Payments
- Haegarda (Biological) $499.42
- Dymista (Drug) $370.72
- NUCALA (Biological) $295.07
- Xolair (Biological) $270.28
- TRELEGY ELLIPTA (Drug) $140.79
- DUPIXENT (Drug) $135.17
- Orladeyo (Drug) $117.21
- RUCONEST (Biological) $113.35
- BREO (Drug) $110.14
- Bellatek (Device) $96.75
- TAKHZYRO (Biological) $92.01
- DUPIXENT (Biological) $74.98
- SPIRIVA RESPIMAT (Drug) $73.44
- BREZTRI (Drug) $60.68
- Auvi-Q (Drug) $58.75
- Epinephrine (Drug) $40.53
- Perjeta (Biological) $31.89
- BREZTRI AEROSPHERE (Drug) $20.40
- XOLAIR (Biological) $20.40
- CINQAIR (Drug) $19.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.